August 29, 2018


Media & events

Play Video


--NIH Grant Fuels Development of Once-Weekly Oral Buprenorphine --

April 9, 2019

Read More

--Lyndra Therapeutics announced that Fujifilm has joined the company’s Series B raise, bringing the total round to $60 million --

February 11, 2019

Read More from Lyndra's COO

-- Lyndra Therapeutics, which is moving toward making daily pills a thing of the past, today announced it has raised $55 million in Series B financing, funds it will use for Phase II clinical trials, expansion of its Phase I pipeline and manufacturing scale-up --

January 29, 2019

Read Press Release Here

-- Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for intellectual property (IP) related to Lyndra’s ultra-long-acting oral drug delivery system--

December 10, 2018

Read Press Release Here

--Study Shows Viability of Taking Once-Weekly Pill--

November 15, 2018

Read Press Release Here

--Study results show novel drug delivery system achieves long-lasting levels of three highly-potent antiretrovirals in the circulation in an animal model--

--Company developing long-acting oral formulations of HIV therapies to address viral resistance and improve therapeutic success--

January 8, 2018

Read Press Release Here

--Companies will collaborate to create products dosed once-weekly for the treatment of Alzheimer’s disease--

September 7, 2017

Read Press Release Here

April 13, 2017

Read Press Release Here

Research by Robert Langer, Giovanni Traverso, Andrew Bellinger and Others Published in Science Translational Medicine

--Novel technology can be applied in fight against malaria and other diseases requiring oral sustained release, long-term drug dosage--

November 16, 2016

Read Press Release Here

Press Coverage